VASARYA THERAPEUTICS, INC.
Biotech · Private
Novel small-molecule drug candidate (VSR-H5) targeting fibroblast activation in idiopathic pulmonary fibrosis
- Grants
- $1.8M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Targeting a disease-specific conformation of fibronectin as a novel approach for liver fibrosis treatment | $295,921 | |
| Federal grant | Department of Health and Human Services · Phase II · Translating a Novel Therapeutic Approach to the Treatment for Idiopathic Pulmonary Fibrosis | $356,250 | |
| Federal grant | Department of Health and Human Services · Phase II · Translating a Novel Therapeutic Approach to the Treatment for Idiopathic Pulmonary Fibrosis | $1,107,500 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2416 | ZYMtronix, Inc. | — | $3.6M |
| 2417 | ProFound Therapeutics | — | — |
| 2418 | ECHOGENESIS THERAPEUTICS INC | — | — |
| 2419 | VASARYA THERAPEUTICS, INC. | — | — |
| 2420 | ANTEANA THERAPEUTICS, INC. | — | — |
| 2421 | ACHEMINALL CORPORATION | — | — |
| 2422 | CARDIOCREATE, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.